0

512217

PRISMMEDI

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

PRISM MEDICO AND PHARMACY LTD. Share Price Today

Investment Returns

Over 1 Month -6.51% Over 3 Months 7.24% Over 6 Months 43.32% Over 1 Year 86.32%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

PRISM MEDICO AND PHARMACY LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 38.00
  • P/E Ratio (TTM) 119.09
  • Beta 0.30
  • Book Value / share 16.89
  • Return on equity -0.33%
  • EPS (TTM) 0.23
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -0.24
info icon alternate text

PRISM MEDICO AND PHARMACY LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 0.28
Operating Expense 0.41
Net Profit -0.24
Net Profit Margin (%) -85.71
Earnings Per Share (EPS) 0.00
EBITDA -0.12
Effective Tax Rate (%) -100.00
Particulars DEC 2025 (Values in Cr)
Revenue 0.07
Operating Expense 0.09
Net Profit -0.01
Net Profit Margin (%) -14.28
Earnings Per Share (EPS) 0.00
EBITDA -0.01
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 0.50
Operating Expense 0.60
Net Profit -0.08
Net Profit Margin (%) -16.00
Earnings Per Share (EPS) 0.00
EBITDA -0.08
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 1.59
Operating Expense 0.94
Net Profit 0.66
Net Profit Margin (%) 41.50
Earnings Per Share (EPS) 0.01
EBITDA 0.65
Effective Tax Rate (%) -1.53
Particulars MAR 2025 (Values in Cr)
Revenue 0.07
Operating Expense 0.06
Net Profit 0.04
Net Profit Margin (%) 57.14
Earnings Per Share (EPS) 0.00
EBITDA 0.02
Effective Tax Rate (%) -100.00
Particulars MAR 2026 (Values in Cr)
Revenue 2.44
Operating Expense 2.04
Net Profit 0.32
Net Profit Margin (%) 13.11
Earnings Per Share (EPS) 0.01
EBITDA 0.43
Effective Tax Rate (%) 25.58
Particulars MAR 2025 (Values in Cr)
Revenue 0.63
Operating Expense 0.71
Net Profit -0.05
Net Profit Margin (%) -7.93
Earnings Per Share (EPS) 0.00
EBITDA -0.07
Effective Tax Rate (%) 28.57
Particulars MAR 2024 (Values in Cr)
Revenue 2.93
Operating Expense 3.07
Net Profit -0.02
Net Profit Margin (%) -0.68
Earnings Per Share (EPS) -0.04
EBITDA 0.00
Effective Tax Rate (%) 33.33
Particulars MAR 2023 (Values in Cr)
Revenue 1.27
Operating Expense 1.37
Net Profit -0.08
Net Profit Margin (%) -6.29
Earnings Per Share (EPS) -0.01
EBITDA -0.09
Effective Tax Rate (%) 30.00
Particulars MAR 2022 (Values in Cr)
Revenue 8.44
Operating Expense 8.94
Net Profit -0.37
Net Profit Margin (%) -4.38
Earnings Per Share (EPS) -0.06
EBITDA -0.49
Effective Tax Rate (%) 26.00
Particulars MAR 2019 (Values in Cr)
Book Value / Share 21.29
ROE % 1.09
ROCE % 1.57
Total Debt to Total Equity 0.17
EBITDA Margin 1.15
Particulars MAR 2018 (Values in Cr)
Book Value / Share 21.23
ROE % -0.16
ROCE % 2.76
Total Debt to Total Equity 0.22
EBITDA Margin 3.84
Particulars MAR 2017 (Values in Cr)
Book Value / Share 21.24
ROE % -1.71
ROCE % -0.43
Total Debt to Total Equity 0.27
EBITDA Margin 2.33
Particulars MAR 2025 (Values in Cr)
Book Value / Share 24.89
ROE % -0.33
ROCE % -0.46
Total Debt to Total Equity 0.00
EBITDA Margin -9.52
Particulars MAR 2024 (Values in Cr)
Book Value / Share 24.97
ROE % -0.13
ROCE % -0.13
Total Debt to Total Equity 0.00
EBITDA Margin -0.34
Particulars MAR 2023 (Values in Cr)
Book Value / Share 25.01
ROE % -0.58
ROCE % -0.79
Total Debt to Total Equity 0.00
EBITDA Margin -7.87
Particulars MAR 2022 (Values in Cr)
Book Value / Share 20.71
ROE % -2.91
ROCE % -3.93
Total Debt to Total Equity 0.00
EBITDA Margin -5.81
Particulars MAR 2021 (Values in Cr)
Book Value / Share 21.32
ROE % -1.00
ROCE % -1.39
Total Debt to Total Equity 0.00
EBITDA Margin -0.95
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 21.20
Total Liabilities 21.20
Total Equity 12.91
Share Outstanding 0
Price to Book Ratio 1.71
Return on Assets (%) 0.18
Return on Capital (%) 0.26
Particulars MAR 2018 (Values in Cr)
Cash & Short Term Investments 1.35
Total Assets 15.79
Total Liabilities 15.79
Total Equity 12.87
Share Outstanding 0
Price to Book Ratio 1.13
Return on Assets (%) -0.02
Return on Capital (%) -0.03
Particulars MAR 2017 (Values in Cr)
Cash & Short Term Investments 1.95
Total Assets 17.26
Total Liabilities 17.26
Total Equity 12.87
Share Outstanding 0
Price to Book Ratio 1.83
Return on Assets (%) -1.26
Return on Capital (%) -1.35
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 15.56
Total Liabilities 15.56
Total Equity 15.09
Share Outstanding 0
Price to Book Ratio 0.47
Return on Assets (%) -0.31
Return on Capital (%) -0.32
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 15.24
Total Liabilities 15.24
Total Equity 15.14
Share Outstanding 0
Price to Book Ratio 1.09
Return on Assets (%) -0.14
Return on Capital (%) -0.14
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 15.39
Total Liabilities 15.39
Total Equity 15.16
Share Outstanding 0
Price to Book Ratio 1.14
Return on Assets (%) -0.49
Return on Capital (%) -0.5
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 12.57
Total Liabilities 12.57
Total Equity 12.55
Share Outstanding 0
Price to Book Ratio 0.37
Return on Assets (%) -2.94
Return on Capital (%) -2.95
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 21.54
Total Liabilities 21.54
Total Equity 12.92
Share Outstanding 0
Price to Book Ratio 0.55
Return on Assets (%) -0.60
Return on Capital (%) -1.01
Particulars MAR 2019 (Values in Cr)
Net Income 0.00
Cash from Operations -0.40
Cash from Investing 0.00
Cash from Financing -0.50
Net change in Cash -0.94
Free Cash Flow -0.40
Particulars MAR 2018 (Values in Cr)
Net Income 0.00
Cash from Operations 3.56
Cash from Investing -2.52
Cash from Financing -1.61
Net change in Cash -0.59
Free Cash Flow 3.56
Particulars MAR 2025 (Values in Cr)
Net Income -0.06
Cash from Operations -0.01
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash -0.01
Free Cash Flow -0.01
Particulars MAR 2024 (Values in Cr)
Net Income -0.02
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash -0.01
Free Cash Flow 0.00
Particulars MAR 2023 (Values in Cr)
Net Income -0.10
Cash from Operations 3.22
Cash from Investing -2.91
Cash from Financing 0.00
Net change in Cash 0.04
Free Cash Flow 3.22
Particulars MAR 2022 (Values in Cr)
Net Income -0.49
Cash from Operations -2.37
Cash from Investing 2.35
Cash from Financing 0.00
Net change in Cash -0.02
Free Cash Flow -2.37
Particulars MAR 2021 (Values in Cr)
Net Income -0.17
Cash from Operations -0.05
Cash from Investing 0.02
Cash from Financing 0.00
Net change in Cash -0.02
Free Cash Flow -0.05
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AEGIS LOGISTICS LTD. 1008.40 39.41 5.84 35394.84 576.00 1016.55
KOTHARI INDUSTRIAL CORP L 162.00 0.00 6.98 1749.95 142.00 624.95
OSWAL AGRO MILLS LTD 43.15 0.00 0.64 579.20 33.50 94.50
DHUNSERI VENTURES LIMITED 245.05 9.42 0.26 858.17 176.20 386.10
RAMA PETROCHEMICALS LTD. 16.08 0.00 -0.39 24.80 11.48 16.92
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AEGIS LOGISTICS LTD. 1008.40 37.51 10.23 35394.84 576.00 1016.55
UTIQUE ENTERPRISES LIMITED 4.16 12.24 0.32 23.16 3.20 6.40
COMPUTER POINT LTD. 3.94 0.00 0.35 11.82 3.41 6.56
KOTHARI INDUSTRIAL CORP L 162.00 0.00 6.98 1749.95 142.00 624.95

PRISM MEDICO AND PHARMACY LTD. shareholding pattern

Holding
69.8%
30.19%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

PRISM MEDICO AND PHARMACY LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
28.00 2.22 redarrow
red-green-graph indicator
6 Bearish
10 Bullish
  • 5 Days 27.40
  • 26 Days 28.40
  • 10 Days 27.70
  • 50 Days 28.20
  • 12 Days 27.90
  • 100 Days 26.40
  • 20 Days 28.30
  • 200 Days 23.90
27.30 PIVOT
First Support 26.59 First Resistance 28.09 Second Support 25.80 Second Resistance 28.80 Third Support 25.09 Third Resistance 29.59
RSI 43.96 ADX 45.98 MACD -0.56 Williams % R -61.28 Commodity Channel Index (CCI) -101.55
Date 2026-06-19 Week 7568.00 Same Day 5372.00 Month 6760.00
1 Year 0.31 3 Year 0.26
Over 1 Month
-6.51% down
Over 1 Year
86.32% down
Over 3 Months
7.24% down
Over 3 Years
1.79% down
Over 6 Months
43.32% down
Over 5 Years
26.45% down

PRISM MEDICO AND PHARMACY LTD. Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Prism Medico & Pharmacy Ltd?

Answer Field

Prism Medico & Pharmacy Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 28.00 as on Jun 22 2026 03:20 PM.

What is the Market Cap of Prism Medico & Pharmacy Ltd Share?

Answer Field

The market cap of Prism Medico & Pharmacy Ltd for NSE ₹ 0.00 & for BSE ₹ 38.00 as on Jun 22 2026 03:20 PM.

What is the 52 Week High and Low of Prism Medico & Pharmacy Ltd?

Answer Field

The 52 Week High and Low of Prism Medico & Pharmacy Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 34.49 and ₹ 12.49.

What is 1 year return for Prism Medico & Pharmacy Ltd?

Answer Field

The 1 year returns on the stock has been 86.32%.

What is the P/E Ratio of Prism Medico & Pharmacy Ltd Share?

Answer Field

As on Jun 22 2026 03:20 PM the price-to-earnings (PE) ratio for Prism Medico & Pharmacy Ltd share is 119.09.

What is the PB ratio of Prism Medico & Pharmacy Ltd Share?

Answer Field

As on Jun 22 2026 03:20 PM, the price-to-book (PB) ratio for Prism Medico & Pharmacy Ltd share is 16.89.

How to Buy Prism Medico & Pharmacy Ltd Share?

Answer Field

You can trade in Prism Medico & Pharmacy Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Prism Medico & Pharmacy Ltd Share on Bajaj Broking App?

Answer Field

To buy Prism Medico & Pharmacy Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Prism Medico & Pharmacy Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|